Mozart Therapeutics
Regulatory CD8 T cells | Autoimmune and Inflammatory diseases
United States · $80.0M raised
- Website
- mozart-tx.com
- Total Funding
- $80.0M
- Last Round
- $25.0M Extension RoundJun 2023
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Clinical-stage biopharmaceutical company developing disease-modifying therapies that restore healthy immune system function to treat autoimmune and inflammatory diseases.
Summary
Mozart Therapeutics is a Biotech company based in United States. It has raised $80.0M in total across 2 rounds, most recently a $25.0M Extension Round in Jun 2023. Investors include ARCH Venture Partners, Sofinnova Partners and UPMC Enterprises.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jun 2023
Sign up to see all 2 events
Funding: Series A through Extension Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/mozart-therapeutics"><img src="https://indexed.vc/api/badge/company/mozart-therapeutics" alt="Mozart Therapeutics on Indexed.vc" width="260" height="76" /></a>